DiscoverLife Sciences DNA PodcastA Venture Studio with Big Pharma Backing Seeks to Fix Drug Development with AI
A Venture Studio with Big Pharma Backing Seeks to Fix Drug Development with AI

A Venture Studio with Big Pharma Backing Seeks to Fix Drug Development with AI

Update: 2024-06-13
Share

Description

Mati Gill, CEO of AION Labs, sits down with Amar Drawid to discuss how the AI venture studio works with its Big Pharma partners to define the biggest drug development hurdles the industry faces; and how it holds challenges to attract academics, entrepreneurs, and life sciences professionals with the best solutions to build new companies.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

A Venture Studio with Big Pharma Backing Seeks to Fix Drug Development with AI

A Venture Studio with Big Pharma Backing Seeks to Fix Drug Development with AI

Levine Media Group